Activated Forms of H-RAS and K-RAS Differentially Regulate Membrane Association of PI3K, PDK-1, and AKT and the Effect of Therapeutic Kinase Inhibitors on Cell Survival

作者: Takehiko Sasazuki , Senji Shirasawa , Xiaoyu Zhu , Paul Dent , Adly Yacoub

DOI:

关键词:

摘要: The abilities of mutated active RAS proteins to modulate cell survival following exposure ionizing radiation and small molecule kinase inhibitors were examined. Homologous recombination in HCT116 cells delete the single allele K-RAS D13 resulted a line that exhibited an ∼75% reduction basal extracellular signal-regulated 1/2, AKT, c- jun -NH2-kinase 1/2 activity. Transfection lacking with H-RAS V12 restored AKT activity levels but did not restore phosphorylation. In expressing V12, caused prolonged intense activation AKT. Inhibition function, blockade phosphatidylinositol 3-kinase (PI3K) function using interfering RNA/small-molecule inhibitors, or expression dominant-negative abolished radiation-induced activation, radiosensitized these cells. PI3K significantly radiosensitize parental Inhibitors PH domain including perifosine, SH-(5, 23-25) ml-(14-16) reduced plating efficiency dose-dependent fashion. perifosine enhanced radiosensitivity cells, whereas SH ml series failed promote toxicity. PI3K, PDK-1, membrane associated, D13, only PDK-1 was bound. associated phosphorylated at Y373/376, which by Src family inhibitor PP2. OSU-03012 PP2 profoundly increased radiosensitivity. had modest inhibitory effects on A RNA generated against PDK1 also V12. Collectively, our data argue molecular inhibition signaling enhances D13. Small-molecule agents blocked stimulated and/or variable enhancing tumor

参考文章(43)
Sophie Grillo, Thierry Grémeaux, Antonio Casamayor, Dario R Alessi, Yannick Le Marchand-Brustel, Jean-François Tanti, Peroxovanadate induces tyrosine phosphorylation of phosphoinositide-dependent protein kinase-1 potential involvement of src kinase. FEBS Journal. ,vol. 267, pp. 6642- 6649 ,(2000) , 10.1046/J.1432-1327.2000.01759.X
Takehiko Sasazuki, Senji Shirasawa, Ryo Iwamoto, Ken Yamamoto, Koji Okumura, Miharu Nishioka, Eisuke Mekada, Iwai Baba, Kayako Fukuyama, Toshiyuki Tsunoda, Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Research. ,vol. 60, pp. 6886- 6889 ,(2000)
P Dent, D B Reardon, D K Morrison, T W Sturgill, Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro. Molecular and Cellular Biology. ,vol. 15, pp. 4125- 4135 ,(1995) , 10.1128/MCB.15.8.4125
Nywana Sizemore, Adrienne D. Cox, John A. Barnard, Sean M. Oldham, Evangeline R. Reynolds, Channing J. Der, Robert J. Coffey, Pharmacological inhibition of ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides Gastroenterology. ,vol. 117, pp. 567- 576 ,(1999) , 10.1016/S0016-5085(99)70449-X
Jung-A Choi, Moon-Taek Park, Chang-Mo Kang, Hong-Duck Um, Sangwoo Bae, Kee-Ho Lee, Tae-Hwan Kim, Jae-Hong Kim, Chul-Koo Cho, Yun-Sil Lee, Hee Yong Chung, Su-Jae Lee, Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Oncogene. ,vol. 23, pp. 9- 20 ,(2004) , 10.1038/SJ.ONC.1206982
Nathan J. Hellyer, Myong-Soo Kim, John G. Koland, Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor. Journal of Biological Chemistry. ,vol. 276, pp. 42153- 42161 ,(2001) , 10.1074/JBC.M102079200
John C Reed, Apoptosis-targeted therapies for cancer. Cancer Cell. ,vol. 3, pp. 17- 22 ,(2003) , 10.1016/S1535-6108(02)00241-6
Tzipora Goldkorn, Naomi Balaban, Mary Shannon, Karen Matsukuma, EGF receptor phosphorylation is affected by ionizing radiation. Biochimica et Biophysica Acta. ,vol. 1358, pp. 289- 299 ,(1997) , 10.1016/S0167-4889(97)00063-3
S. Wang, W. S. El-Deiry, Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 15095- 15100 ,(2003) , 10.1073/PNAS.2435285100
John C. Reed, Apoptosis-based therapies Nature Reviews Drug Discovery. ,vol. 1, pp. 111- 121 ,(2002) , 10.1038/NRD726